See also stories tagged with Microfluidics
When an individual has cancer, or any number of other diseases, early detection can make a huge difference in the outcome. A research team led by the University of Notre Dame is working to cut the test time for disease biomarkers. ...
Recently ANSTO researchers have made progress investigating improved ways to make life-saving radiopharmaceuticals using the fluorine-18 radioisotope so they can be available in more hospitals at lower cost.
Instead of searching for a needle in a haystack, what if you were able to sweep the entire haystack to one side, leaving only the needle behind? That's the strategy researchers in the University of Georgia College of Engineering ...
A simple innovation the size of a grain of sand means we can now analyse cells and tiny particles as if they were inside the human body.
Nanoparticles (NPs) are a promising platform for drug delivery to treat a variety of diseases including cancer, cardiovascular disease and inflammation. Yet the efficiency of NP transfer to the diseased tissue of interest ...
Medical professionals may soon be able to detect bacteria in patient samples in minutes rather than days thanks to a new approach that traps and tests single cells, according to a team of biomedical engineers.
MIT engineers have designed tiny robots that can help drug-delivery nanoparticles push their way out of the bloodstream and into a tumor or another disease site. Like crafts in "Fantastic Voyage"—a 1960s science fiction ...
Researchers from ETH Zurich demonstrate that genetically identical cells exhibit differing responses in their motility towards chemical attractants. Average values hide the full picture when it comes to describing the behavior ...
Nearing a decision point, online traffic maps recommend a less-crowded route over the other ways with several slow spots. For most of us, the choice seems clear. Still, have you ever wondered whether this collectively preferring ...
A KAIST research team developed a microfluidic-based drug screening chip that identifies synergistic interactions between two antibiotics in eight hours. This chip can be a cell-based drug screening platform for exploring ...
